Mendoza-Sánchez F, Ángeles-Bueno WG, Montes-López GA, Mendoza-Medina DF, Díaz-Sifuentes JM, Pérez-Landeros JE

Language: Spanish
References: 11
Page: 28-32
PDF size: 494.67 Kb.

ABSTRACT

Background: The successful performance of ostomies for the treatment of different diseases has been described since 1706. We report herein the first case of successful ostomy utilizing a synthetic stoma created in a patient with peritoneal carcinomatosis. Clinical case: A 40-year-old woman presented with abdominal carcinomatosis due to psammomatous papillotubular adenocarcinoma consistent with primary ovarian carcinoma. The patient had negative estrogen and progesterone receptors and Ki-67 proliferative activity was 83%. She was initially treated with cytoreduction therapy, chemotherapy, and hyperthermic intraperitoneal chemotherapy. Because the patient presented with enteric perforations and the extensive tumor invasion and adhesions in all the intestinal segments made it impossible to create autologous decompression stomas, a synthetic stoma was constructed. Conclusions: Synthetic stomas can be a good treatment option when autologous stomas can not be created.

REFERENCES

1. Correa-Rovelo JM, Vargas RG, Vélez-Pérez FM, Díaz-Girón A. Estomas en coloproctología. En: Morales-Saavedra JL, Torres-Rodríguez VB (eds.). Tratado de cirugía general, vol. II, 3ra ed. Ciudad de México: El Manual Moderno, 2017:1317-1325.

2. Hardy KJ. Surgical history. Evolution of the stoma. Aust N Z J Surg. 1989;59:71-7.

3. Littré A. Quoted in Dinnick T. The origins and evolution of colostomy. Br J Surg 1934;22:142-154.

4. Miller ZA, Mohan P, Tartaglione R, Narayanan G. Bowel obstruction: decompressive gastrostomies and cecostomies. Semin Intervent Radiol. 2017;34:349-360.

5. Huang T, Nakamuro M, Nakano H, Okubo Y, Kondo Y, Ishikawa K, et al. Successful multidisciplinary treatment of metastatic ovarian cancer after perforative peritonitis of the rectum due to disseminated ovarian cancer. Gan To Kagaku Ryoho. 2016;43:2136-2138.

6. Yetisir F, Salman AE, Acar HZ, Özer M, Aygar M, Osmanoglu G. Management of septic open abdomen in a morbid obese patient with enteroatmospheric fistula by using standard abdominal negative pressure therapy in conjunction with intrarectal one. Case Rep Surg. 2015; 2015:293946.

7. Schneider F, O’Connor S, Becquemin JP. Efficacy of collagen silver-coated polyester and rifampin-soaked vascular grafts to resist infection from MRSA and Escherichia coli in a dog model. Ann Vasc Surg 2008;22:815-821.

8. Qi WX, Shen Z, Tang LN, Yao Y. Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups. Eur J Clin Pharmacol. 2014;70:893-906.

9. Chouliaras K, Levine EA, Fino N, Shen P, Votanopoulos KI. Prognostic factors and significance of gastrointestinal leak after cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2017;24:890-897.

10. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008; 15:2426-32.

11. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449-56.